HK1012017A1 - Lipopeptid-derivatives, process for their preparation and their use - Google Patents

Lipopeptid-derivatives, process for their preparation and their use

Info

Publication number
HK1012017A1
HK1012017A1 HK98113243A HK98113243A HK1012017A1 HK 1012017 A1 HK1012017 A1 HK 1012017A1 HK 98113243 A HK98113243 A HK 98113243A HK 98113243 A HK98113243 A HK 98113243A HK 1012017 A1 HK1012017 A1 HK 1012017A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
lipopeptid
preparation
lipopeptide derivatives
bacterial infections
Prior art date
Application number
HK98113243A
Other languages
English (en)
Inventor
Rudolf Lattrell
Theodor Wollmann
Holger Wallmeier
Peter Hammann
Dieter Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HK1012017A1 publication Critical patent/HK1012017A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98113243A 1994-03-30 1998-12-12 Lipopeptid-derivatives, process for their preparation and their use HK1012017A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
HK1012017A1 true HK1012017A1 (en) 1999-07-23

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113243A HK1012017A1 (en) 1994-03-30 1998-12-12 Lipopeptid-derivatives, process for their preparation and their use

Country Status (25)

Country Link
US (1) US5629288A (xx)
EP (1) EP0688789B1 (xx)
JP (1) JP3653119B2 (xx)
KR (1) KR100360129B1 (xx)
CN (1) CN1111640A (xx)
AT (1) ATE219499T1 (xx)
AU (1) AU696566B2 (xx)
CA (1) CA2145826C (xx)
CZ (1) CZ287158B6 (xx)
DE (2) DE4411025A1 (xx)
DK (1) DK0688789T3 (xx)
ES (1) ES2178657T3 (xx)
FI (1) FI951468A (xx)
HK (1) HK1012017A1 (xx)
HU (1) HU218286B (xx)
IL (1) IL113160A (xx)
MA (1) MA23490A1 (xx)
NO (1) NO951198L (xx)
NZ (1) NZ270828A (xx)
OA (1) OA10142A (xx)
PL (1) PL180274B1 (xx)
PT (1) PT688789E (xx)
RU (1) RU2141970C1 (xx)
TW (1) TW336939B (xx)
ZA (1) ZA952555B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
WO1999020651A1 (fr) * 1997-10-21 1999-04-29 Sankyo Company, Limited Nouveaux composes antifongiques
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
AU3837600A (en) * 1999-04-16 2000-11-02 Sankyo Company Limited Novel antifungal compounds
EP2295444A3 (en) 1999-12-15 2011-03-23 Cubist Pharmaceutical Inc. Lipopeptides as antibacterial agents
KR20020063230A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서의 신규한 리포펩티드
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
AU7893301A (en) * 2000-07-17 2002-01-30 Intrabiotics Pharmaceuticals Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
NZ554405A (en) 2000-12-18 2009-04-30 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified lipopeptides
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
AU2002353775A1 (en) * 2001-08-06 2003-03-10 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
US7125844B2 (en) * 2002-01-03 2006-10-24 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
NZ544750A (en) * 2003-07-17 2009-06-26 Migenix Inc Compositions of amphomycin or aspartocin based lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US8299795B2 (en) * 2007-02-19 2012-10-30 Schlumberger Technology Corporation Independently excitable resistivity units
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
CA2747965C (en) * 2008-12-22 2017-06-27 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of gram positive infections
PE20151717A1 (es) 2009-11-23 2015-11-19 Cubist Pharm Inc Compuestos lipopeptidos y metodos relacionados
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
AU696566B2 (en) 1998-09-10
PT688789E (pt) 2002-11-29
AU1611095A (en) 1995-10-12
NZ270828A (en) 1996-10-28
HU218286B (en) 2000-07-28
KR950032636A (ko) 1995-12-22
CN1111640A (zh) 1995-11-15
ES2178657T3 (es) 2003-01-01
NO951198L (no) 1995-10-02
CZ77995A3 (en) 1995-10-18
FI951468A0 (fi) 1995-03-28
IL113160A0 (en) 1995-06-29
US5629288A (en) 1997-05-13
ZA952555B (en) 1995-12-21
JP3653119B2 (ja) 2005-05-25
FI951468A (fi) 1995-10-01
HUT71584A (en) 1995-12-28
PL307914A1 (en) 1995-10-02
CZ287158B6 (en) 2000-10-11
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
KR100360129B1 (ko) 2003-03-26
EP0688789A1 (de) 1995-12-27
DE4411025A1 (de) 1995-10-05
CA2145826A1 (en) 1995-10-01
ATE219499T1 (de) 2002-07-15
NO951198D0 (no) 1995-03-29
PL180274B1 (pl) 2001-01-31
JPH07278186A (ja) 1995-10-24
RU2141970C1 (ru) 1999-11-27
TW336939B (en) 1998-07-21
RU95106362A (ru) 1996-12-27
DK0688789T3 (da) 2002-10-14
OA10142A (fr) 1996-12-18
CA2145826C (en) 2008-01-08
DE59510246D1 (de) 2002-07-25
MA23490A1 (fr) 1995-10-01

Similar Documents

Publication Publication Date Title
ZA952555B (en) Lipopeptide derivatives a process for their preparation and their use
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
BG103947A (en) Derivatives of 9-oxymerythromycin
AU2067692A (en) New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them
MX9708696A (es) Cefalosporinas antibacterianas.
GR3036873T3 (en) Dialkyltiacumicin compounds
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
NZ227990A (en) Cephemcarboxylic acid esters; pharmaceutical compositions and processes for preparation
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
TW252979B (xx)
AU5522794A (en) New angiopeptin cyclopeptide compounds, process for the preparation thereof, and pharmaceutical compositios containing them
IL89126A0 (en) Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
ES2002903A6 (es) Procedimiento para preparar derivados de cefalosporina
AU7411291A (en) Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060324